NCR Tables - Distribution By Histopathology Findings

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AB02	REMSIMA	BioTech	Infliximab - 100mg	100mg	Injectable concentrated powder for solution	24,943,134 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 500mg	500mg	Injectable concentrated powder for solution	75,811,351 L.L
L01BA04	PEMETREXED SPC	G	Pemetrexed (disodium) - 500mg	500mg	Injectable concentrated powder for solution	43,746,515 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
L01CD01	PACLITAXEL MYLAN PHARMA 6MG/ML	G	Paclitaxel - 300mg/50ml	300mg/50ml	Injectable concentrated powder for solution	50,777,144 L.L
J02AX04	CANCIDAS	B	Caspofungin (acetate) - 70mg	70mg	Injectable concentrated powder for solution	31,611,335 L.L
L01CD01	PACLITAXEL MYLAN PHARMA 6MG/ML	G	Paclitaxel - 30mg/5ml	30mg/5ml	Injectable concentrated powder for solution	5,698,047 L.L
J02AX04	CASPOFUNGINE STRAGEN	G	Caspofungin (acetate) - 70mg	70mg	Injectable concentrated powder for solution	22,928,852 L.L
J02AX04	CANCIDAS	B	Caspofungin (acetate) - 50mg	50mg	Injectable concentrated powder for solution	25,799,521 L.L
J02AX04	CASPOFUNGINE STRAGEN	G	Caspofungin (acetate) - 50mg	50mg	Injectable concentrated powder for solution	18,712,833 L.L
L01CD01	PACLITAXEL MYLAN PHARMA 6MG/ML	G	Paclitaxel - 100mg/16.7ml	100mg/16.7ml	Injectable concentrated powder for solution	21,556,419 L.L
J02AX06	ECALTA	B	Anidulafungin - 100mg	100mg	Injectable concentrated powder for solution	16,977,343 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
J01DH03	INVANZ	B	Ertapenem - 1g	1g	Injectable concentrated powder for solution	3,785,604 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 100mg/20ml	5mg/ml	Injectable concentrated solution	8,471,583 L.L
L01XA03	OXALIPLATIN EBEWE	G	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	3,405,297 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 50mg/10ml	5mg/ml	Injectable concentrated solution	3,450,988 L.L
L01CE02	IRINOTECAN THYMOORGAN	G	Irinotecan HCl - 100mg/5ml	100mg/5ml	Injectable concentrated solution	6,111,796 L.L
L01CE02	IRINOTECAN THYMOORGAN	G	Irinotecan HCl - 40mg/2ml	40mg/2ml	Injectable concentrated solution	2,123,271 L.L
L01FD02	PERJETA 420MG	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 300mg/10ml	300mg/10ml	Injectable concentrate for solution	547,517,314 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	22,183,393 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	11,091,696 L.L
L01FA01	RIXATHON	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	27,354,833 L.L
L01FA01	RUXIENCE	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	13,157,756 L.L
J01MA23	BAXDELA	B	Delafloxacin - 300mg	300mg	Injectable concentrate for solution	78,349,010 L.L
L01FA01	TRUXIMA	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	31,060,158 L.L
L01FA01	ZYTUX	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	16,463,240 L.L

جداول بيانية لسجل الوطني للسرطان - توزيع الحالات حسب خصائص الانسجة